IMUX Announces $400M Private Placement, $200M Upfront, to Fund Phase 3 Trials, Commercialization
Immunic, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $15.13
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS